[go: up one dir, main page]

WO1997032992B1 - Lignees cellulaires hematopoietiques immortalisees, systeme cellulaire de ces lignees avec des cellules du stroma, applications in vitro, ex vivo et in vivo, et generation in vivo de cellules dendritiques et de macrophages - Google Patents

Lignees cellulaires hematopoietiques immortalisees, systeme cellulaire de ces lignees avec des cellules du stroma, applications in vitro, ex vivo et in vivo, et generation in vivo de cellules dendritiques et de macrophages

Info

Publication number
WO1997032992B1
WO1997032992B1 PCT/US1997/003186 US9703186W WO9732992B1 WO 1997032992 B1 WO1997032992 B1 WO 1997032992B1 US 9703186 W US9703186 W US 9703186W WO 9732992 B1 WO9732992 B1 WO 9732992B1
Authority
WO
WIPO (PCT)
Prior art keywords
cells
stem cells
hematopoietic stem
cell
hematopoietic
Prior art date
Application number
PCT/US1997/003186
Other languages
English (en)
Other versions
WO1997032992A1 (fr
Filing date
Publication date
Priority claimed from US08/612,302 external-priority patent/US5811297A/en
Application filed filed Critical
Priority to EP97915851A priority Critical patent/EP0954594A2/fr
Priority to JP9531851A priority patent/JP2000508885A/ja
Publication of WO1997032992A1 publication Critical patent/WO1997032992A1/fr
Publication of WO1997032992B1 publication Critical patent/WO1997032992B1/fr

Links

Abstract

Cette invention concerne des lignées cellulaires hématopoïétiques ayant une durée de vie plus longue, notamment des lignées cellulaires du stroma utiles dans la conservation in vitro de cellules souches hématopoïétiques pluripotentielles non différentiées. Les cellules souches immortalisées différentiées et non différentiées peuvent être utilisées dans la transplantation de moelle osseuse, dans des applications de thérapie génique et de thérapie cellulaire, ainsi que dans des systèmes de modèles in vitro afin de découvrir des médicaments ou d'effectuer des analyses toxicologiques.
PCT/US1997/003186 1996-03-07 1997-03-07 Lignees cellulaires hematopoietiques immortalisees, systeme cellulaire de ces lignees avec des cellules du stroma, applications in vitro, ex vivo et in vivo, et generation in vivo de cellules dendritiques et de macrophages WO1997032992A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP97915851A EP0954594A2 (fr) 1996-03-07 1997-03-07 Lignees cellulaires hematopoietiques immortalisees, systeme cellulaire de ces lignees avec des cellules du stroma, applications in vitro, ex vivo et in vivo, et generation in vivo de cellules dendritiques et de macrophages
JP9531851A JP2000508885A (ja) 1996-03-07 1997-03-07 不死化造血細胞系、該細胞系とストロマ細胞との細胞システム、ｉｎ ｖｉｔｒｏ、ｅｘ ｖｉｖｏ および ｉｎ ｖｉｖｏ における使用、ならびに樹状細胞およびマクロファージの ｉｎ ｖｉｔｒｏ 産生

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/612,302 US5811297A (en) 1996-03-07 1996-03-07 Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, & in vitro generation of dendritic cells and macrophages
US08/612,302 1996-03-07

Publications (2)

Publication Number Publication Date
WO1997032992A1 WO1997032992A1 (fr) 1997-09-12
WO1997032992B1 true WO1997032992B1 (fr) 1997-11-06

Family

ID=24452603

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/003186 WO1997032992A1 (fr) 1996-03-07 1997-03-07 Lignees cellulaires hematopoietiques immortalisees, systeme cellulaire de ces lignees avec des cellules du stroma, applications in vitro, ex vivo et in vivo, et generation in vivo de cellules dendritiques et de macrophages

Country Status (5)

Country Link
US (1) US5811297A (fr)
EP (1) EP0954594A2 (fr)
JP (1) JP2000508885A (fr)
CA (1) CA2248555A1 (fr)
WO (1) WO1997032992A1 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5670347A (en) * 1994-05-11 1997-09-23 Amba Biosciences Llc Peptide-mediated gene transfer
US6008202A (en) * 1995-01-23 1999-12-28 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US5795587A (en) 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
US20030069173A1 (en) * 1998-03-16 2003-04-10 Life Technologies, Inc. Peptide-enhanced transfections
AUPO723097A0 (en) * 1997-06-06 1997-07-03 Australian National University, The A method for culturing cells
PT1071747E (pt) * 1998-04-17 2004-12-31 Nestle Sa Linhas celulares imortalizadas derivadas de tecidos cutaneos humanos normais
JP2002531852A (ja) * 1998-12-09 2002-09-24 ビスタジェン インコーポレイテッド 胚様体を用いる毒性の分類
AU3755800A (en) * 1999-03-15 2000-10-04 Introgen Therapeutics, Inc. Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses
AU4366000A (en) 1999-04-14 2000-11-14 Chiron Corporation Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
WO2000073432A2 (fr) * 1999-06-01 2000-12-07 Cornell Research Foundation, Inc. Activation de cellules dendritiques pour accroitre l'immunite
AU2001268399A1 (en) * 2000-06-14 2001-12-24 Vistagen, Inc. Toxicity typing using mesenchymal stem cells
AU2001268449A1 (en) 2000-06-14 2001-12-24 Vistagen, Inc. Toxicity typing using liver stem cells
US20030202963A1 (en) * 2000-10-12 2003-10-30 Cornell Research Foundation, Inc. Method of treating cancer
EP1351969A4 (fr) * 2000-12-13 2006-04-05 Immunex Corp Procede relatif a l'elaboration de lignees cellulaires dendritiques immortelles
US20030027334A1 (en) * 2000-12-13 2003-02-06 Fitzpatrick David R. Method for generating immortal dendritic cell lines
DE10139428A1 (de) * 2001-08-17 2003-03-27 Nemod Immuntherapie Ag Herstellung und Verwendung von humanen CD124 und CD116 positiven Tumorzelllinien zur Herstellung von allogenen oder semi-allogenen Immuntherapeutika
US20050084959A1 (en) * 2001-10-31 2005-04-21 Hirofumi Hamada Immortalized mesenchymal cells and utilization thereof
CA2466880A1 (fr) * 2001-11-09 2003-05-15 Artecel Sciences, Inc. Methodes et compositions dans lesquelles on utilise des cellules stromales pour supporter des cellules souches embryonnaires et adultes
AU2002360674A1 (en) * 2001-12-21 2003-07-30 The United States Of America Represented By The Secretary Of The U.S. Department Of The Navy In increasing gene transfer efficiency by pre-incubation with endothelial cells
WO2006124700A2 (fr) * 2005-05-12 2006-11-23 Introgen Therapeutics, Inc. Vaccins p53 permettant de traiter les cancers
WO2007026353A2 (fr) 2005-08-29 2007-03-08 Technion Research & Development Foundation Ltd. Milieux de culture de cellules souches
EP2059586B1 (fr) 2006-08-02 2016-07-20 Technion Research & Development Foundation Ltd. Procédés d'expansion de cellules souches embryonnaires dans une culture en suspension
JP5227317B2 (ja) * 2007-05-17 2013-07-03 ディナベック株式会社 樹状細胞の製造方法
NZ582616A (en) * 2007-06-15 2012-07-27 Garnet Biotherapeutics Inc Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro
US10894944B2 (en) * 2009-04-10 2021-01-19 Monash University Cell culture media
EP3633025B1 (fr) 2009-11-12 2022-09-14 Technion Research & Development Foundation Ltd. Milieu de culture, cultures de cellules et procédés de culture de cellules souches pluripotentes dans un état indifférencié
JP6126004B2 (ja) 2010-10-25 2017-05-10 ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアＴｈｅ Ｃｈｉｌｄｒｅｎ’Ｓ Ｈｏｓｐｉｔａｌ Ｏｆ Ｐｈｉｌａｄｅｌｐｈｉａ 血小板の生成のための組成物および方法、およびそれらの使用の方法
ES2686851T3 (es) * 2013-04-09 2018-10-22 Inserm - Institut National De La Santé Et De La Recherche Médicale Uso de M-CSF para prevenir o tratar la citopenia mieloide y las complicaciones relacionadas
US10987670B2 (en) 2015-04-14 2021-04-27 President And Fellows Of Harvard College Electrode array for vortex-assisted electroporation
WO2017066624A1 (fr) * 2015-10-15 2017-04-20 President And Fellows Of Harvard College Immortalisation de cellules par administration de gènes d'électroporation assistée par vortex

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950700403A (ko) * 1992-03-04 1995-01-16 죤 제이. 쉬바르츠 조혈 간세포의 배양 및 그것의 유전공학(culturing of hematopoietic stem cells and their genetic engineering)
EP0563485A1 (fr) * 1992-03-30 1993-10-06 Schering-Plough Génération in vitro de cellules dendritiques humaines et leurs usages
AU8014694A (en) * 1993-10-07 1995-05-01 Systemix, Inc. Methods for analysis of human stem cells
US5599703A (en) * 1993-10-28 1997-02-04 The United States Of America As Represented By The Secretary Of The Navy In vitro amplification/expansion of CD34+ stem and progenitor cells
US5599705A (en) * 1993-11-16 1997-02-04 Cameron; Robert B. In vitro method for producing differentiated universally compatible mature human blood cells
US5670347A (en) * 1994-05-11 1997-09-23 Amba Biosciences Llc Peptide-mediated gene transfer
US6103522A (en) * 1994-07-20 2000-08-15 Fred Hutchinson Cancer Research Center Human marrow stromal cell lines which sustain hematopoiesis

Similar Documents

Publication Publication Date Title
WO1997032992B1 (fr) Lignees cellulaires hematopoietiques immortalisees, systeme cellulaire de ces lignees avec des cellules du stroma, applications in vitro, ex vivo et in vivo, et generation in vivo de cellules dendritiques et de macrophages
Rheinwald et al. Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes
Elder et al. Effect of compressive loading on chondrocyte differentiation in agarose cultures of chick limb‐bud cells
Zweigerdt et al. Generation of confluent cardiomyocyte monolayers derived from embryonic stem cells in suspension: a cell source for new therapies and screening strategies
Snir et al. Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes
CN101696397B (zh) 来自人胚胎干细胞的间充质细胞和成骨细胞
Zandstra et al. Leukemia inhibitory factor (LIF) concentration modulates embryonic stem cell self‐renewal and differentiation independently of proliferation
US6432711B1 (en) Embryonic stem cells capable of differentiating into desired cell lines
Ouyang et al. Long-term culturing of undifferentiated embryonic stem cells in conditioned media and three-dimensional fibrous matrices without extracellular matrix coating
Martin et al. A relativity concept in mesenchymal stromal cell manufacturing
US5811297A (en) Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, & in vitro generation of dendritic cells and macrophages
CA2330190A1 (fr) Regulation d'une differenciation de cellules souches hematopoietiques au moyen de cellules souches mesenchymateuses humaines
MXPA04004310A (es) Metodos y composiciones para el uso de celulas estromales para soportar celulas madre embrionarias y adultas.
Kitala et al. Amniotic cells share clusters of differentiation of fibroblasts and keratinocytes, influencing their ability to proliferate and aid in wound healing while impairing their angiogenesis capability
US20050054100A1 (en) Methods for fibroblast differentiation
Grosjean et al. S-phase synchronized CHO cells show elevated transfection efficiency and expression using CaPi
IL138417A0 (en) Immortalised cell lines derived from normal human skin tissues
Zhao et al. The CD200/CD200R mechanism in mesenchymal stem cells’ regulation of dendritic cells
Grossi et al. Generation of knockout human primary keratinocytes by CRISPR/Cas9
Handschel et al. Embryonic stem cells in scaffold-free three-dimensional cell culture: osteogenic differentiation and bone generation
Li et al. Hair growth in vitro from histocultured skin
Sun et al. Selective growth of some rodent epithelial cells in a medium containing citrulline.
Young et al. In vitro senescence occurring in normal human endothelial cells can be rescued by ectopic telomerase activity
Van den Plas et al. Efficient removal of LoxP-flanked genes by electroporation of Cre-recombinase mRNA
Emami et al. Enhanced growth of canine bone marrow stromal cell cultures in the presence of acidic fibroblast growth factor and heparin